Akanda (AKAN) Total Non-Current Liabilities (2020 - 2025)
Akanda (AKAN) recorded quarterly Total Non-Current Liabilities of $70869.0 in Q2 2025, down 98.05% quarter-over-quarter from $3.6 million in Q4 2024.
Akanda (AKAN) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends
Akanda's Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $70869.0 for Q2 2025.
- In Q2 2025, Total Non-Current Liabilities changed N/A year-over-year to $70869.0; the TTM figure through Jun 2025 stood at $70869.0 (changed N/A YoY), while the FY2024 annual figure was $3.6 million, up 45.67% from the prior year.
- Total Non-Current Liabilities was $70869.0 for Q2 2025 at Akanda, down from $3.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $3.6 million in Q4 2024 to a low of $70869.0 in Q2 2025.
- Historically, Total Non-Current Liabilities has averaged $2.3 million across 5 years, with a median of $2.5 million in 2023.
- The sharpest annual moves came in 2021 and 2024: Total Non-Current Liabilities tumbled 69.9% in 2021, then jumped 45.67% in 2024.
- A 5-year view of Total Non-Current Liabilities shows it stood at $2.0 million in 2021, then soared by 38.9% to $2.7 million in 2022, then fell by 9.16% to $2.5 million in 2023, then soared by 45.67% to $3.6 million in 2024, then slumped by 98.05% to $70869.0 in 2025.
- The last three Total Non-Current Liabilities figures came in at $70869.0 (Q2 2025), $3.6 million (Q4 2024), and $2.5 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Akanda | 826.99 Mn | 824.46 Mn | - | 11.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.99 Mn |
| Jun 30, 2025 | 70,869.00 |
| Dec 31, 2024 | 3.64 Mn |
| Dec 31, 2023 | 2.50 Mn |
| Jun 30, 2023 | 2.48 Mn |
| Dec 31, 2022 | 2.75 Mn |
| Jun 30, 2022 | 2.57 Mn |
| Dec 31, 2021 | 1.98 Mn |
| Dec 31, 2020 | 6.58 Mn |